MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Ataxia-Teleangiectasia-Mutated-Knock-Out mouse cerebellum shows significant reduction of calcium homeostasis factors

J. Canet-Pons, R. Schubert, U. Warnken, M. Schnoelzer, S. Zielen, G. Auburger (Frankfurt am Main, Germany)

Meeting: 2017 International Congress

Abstract Number: 788

Keywords: Ataxia: Pathophysiology

Session Information

Date: Wednesday, June 7, 2017

Session Title: Ataxia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: We aimed to identify sensitive and specific molecular markers of the cerebellar Purkinje neuron loss in Ataxia Teleangiectasia.

Background: Ataxia teleangiectasia is an autosomal recessively inherited disorder with loss of cerebellar Purkinje neurons and a deficient immune defense. The causative loss-of-function mutations in the Ataxia-Teleangiectasia-Mutated (ATM) gene hinder the repair of DNA-damage events. The corresponding mouse model with Atm-knock-out dies around the age of 4-6 months due to thymic lymphomas, without showing histological or behavioral signs of cerebellar damage.

Methods: We assessed a number of molecular markers of cerebellar Purkinje neuron loss, which were previously defined in the autosomal dominantly inherited Spinocerebellar Ataxia type 2 (SCA2) cerebellar tissue from patient autopsies and mouse models. As a sensitive detection method with near-linear correlation, quantitative reverse-transcriptase polymerase chain reaction was employed to measure the expression of candidate factor expression. Tata-binding-protein (Tbp) mRNA was used as loading control.

Results: Two known markers of cerebellar Purkinje neurons, Calbindin-1 (Calb1) and Inositol-Tris-Phosphate-Receptor-1 (Itpr1) showed significant reductions to 80% expression of the respective transcripts already at age 3 months (n = 8 KO vs 8 WT). Additional analyses of Reelin pathway components and DNA-damage markers are ongoing. Different ages and a comparison of homozygotes with heterozygotes are under study, to define the usefulness of these molecules as progression markers. 

Conclusions: Our identification of two calcium homeostasis factors as pre-symptomatic molecular markers of cerebellar Purkinje neuron loss will be useful to assess the neuroprotective potential of novel therapeutic approaches, such as bone marrow transplantation and anti-oxidative drugs.

To cite this abstract in AMA style:

J. Canet-Pons, R. Schubert, U. Warnken, M. Schnoelzer, S. Zielen, G. Auburger. Ataxia-Teleangiectasia-Mutated-Knock-Out mouse cerebellum shows significant reduction of calcium homeostasis factors [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/ataxia-teleangiectasia-mutated-knock-out-mouse-cerebellum-shows-significant-reduction-of-calcium-homeostasis-factors/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/ataxia-teleangiectasia-mutated-knock-out-mouse-cerebellum-shows-significant-reduction-of-calcium-homeostasis-factors/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley